In breast cancer cells, TFPI2 binds AP-2α, preventing its interaction with the MMP-2 promoter, reducing transcriptional activity, mRNA, and protein levels, thereby inhibiting proliferation and invasion [30] (Figure 2(1)). This evidence concerns the gene TFPI2 and breast carcinoma.